It was a double-portion of good news for Trinity-Chiesi this week after the firm launched its promising new asthma treatment Fostair in the UK, and received a nod from the Scottish Medicines ...

Chiesi Limited, the UK affiliate of Italian healthcare company Chiesi Farmaceutici, has launched a new mobile app for adult patients with asthma or chronic obstructive pulmonary disease (COPD) to ...

Lupin's UK subsidiary, Lupin Healthcare (UK), has received the drug regulator Medicines and Healthcare products Regulatory Agency's approval to market Luforbec, the first branded generic of asthma ...

Switching patients to a beclomethasone/formoterol inhaler can significantly boost asthma control and reduce costs, suggests a new study. The study found using a ...

Lupin receives UK marketing authorisation for Luforbec® 100/6 pMDI, first branded generic alternative to Fostair® to treat Asthma & COPD Slough, UK, June 14, 2021: Lupin Healthcare, the UK-based ...